Medicare Enrolled
Dr. Jagan Akella, MD
Cardiovascular Disease · Bradenton, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Akella from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akella? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akella
Dr. Jagan Akella is a cardiovascular disease in Bradenton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Akella performed 8,708 Medicare services across 4,724 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akella received a total of $11,697 from 44 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akella is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in FL$ $11,697 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,708
Medicare services
Top 9% in FL for cardiovascular disease
4,724
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~458 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,048 | $93 | $209 |
| Hospital follow-up visit, high complexity | 1,050 | $94 | $238 |
| Electrocardiogram (EKG), 12-lead | 994 | $10 | $29 |
| Regadenoson injection (Lexiscan) for heart stress test | 813 | $42 | $123 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 676 | $88 | $230 |
| Echocardiogram, transthoracic | 587 | $139 | $380 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 349 | $47 | $137 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 344 | $328 | $842 |
| Initial hospital admission, high complexity | 206 | $135 | $347 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 166 | $40 | $109 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 154 | $28 | $72 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 113 | $21 | $53 |
| New patient office visit (45-59 min) | 102 | $118 | $279 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 95 | $18 | $47 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 92 | $9 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 90 | $2 | $6 |
| Ultrasound of heart with probe in esophagus, with report | 84 | $82 | $210 |
| Ultrasound of heart blood flow, valves and chambers | 84 | $14 | $35 |
| Remote pacemaker/defibrillator monitoring, 90 days | 77 | $17 | $43 |
| Remote pacemaker monitoring, 90 days | 58 | $23 | $60 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 58 | $20 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 54 | $53 | $142 |
| Ultrasound of leg arteries or artery grafts | 48 | $176 | $462 |
| Repair of left upper heart chamber with implant with review by radiologist | 43 | $626 | $1,625 |
| Ultrasound of both sides of head and neck blood flow | 42 | $141 | $371 |
| Cardiac catheterization | 38 | $233 | $599 |
| Office visit, established patient (20-29 min) | 32 | $61 | $157 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 28 | $46 | $139 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $408 | $1,073 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $769 | $1,968 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 25 | $117 | $350 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $29 | $73 |
| Programming of dual lead pacemaker system | 15 | $57 | $155 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 14 | $194 | $522 |
| New patient office visit (30-44 min) | 14 | $75 | $201 |
| Office visit, established patient, complex (40-54 min) | 14 | $113 | $287 |
| Insertion of permanent leadless pacemaker using imaging guidance | 13 | $327 | $980 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 12 | $141 | $364 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.7% high complexity
19.6% medium
65.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,697
Total received (2018-2024)
Avg $1,671/year across 7 years
Top 22% in FL for cardiovascular disease
44
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,583 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,657
2023$1,615
2022$1,515
2021$1,553
2020$1,159
2019$997
2018$3,201
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,303
Boston Scientific Corporation
$1,277
Janssen Pharmaceuticals, Inc
$1,268
Medtronic Vascular, Inc.
$1,011
PFIZER INC.
$637
E.R. Squibb & Sons, L.L.C.
$598
Novartis Pharmaceuticals Corporation
$535
Medtronic, Inc.
$435
AstraZeneca Pharmaceuticals LP
$417
BIOTRONIK INC.
$382
SANOFI-AVENTIS U.S. LLC
$353
Boehringer Ingelheim Pharmaceuticals, Inc.
$350
Alnylam Pharmaceuticals Inc.
$313
AtriCure, Inc.
$290
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$201
Biosense Webster, Inc.
$195
Reflow Medical Inc
$185
Astellas Pharma US Inc
$175
CARDIVA MEDICAL, INC.
$166
Kestra Medical Technology Services, Inc.
$164
Inari Medical, Inc.
$161
ARALEZ PHARMACEUTICALS US INC.
$143
Lundbeck LLC
$143
PORTOLA PHARMACEUTICALS, LLC
$107
Amgen Inc.
$105
Bardy Diagnostics, Inc.
$90
BOSTON SCIENTIFIC CORPORATION
$87
iRhythm Technologies, Inc.
$83
Cardinal Health 200, LLC
$74
Merck Sharp & Dohme Corporation
$61
Esperion Therapeutics, Inc.
$48
CVRx, Inc.
$44
Aziyo Biologics, Inc.
$40
W. L. Gore & Associates, Inc.
$38
Terumo Medical Corporation
$35
Merck Sharp & Dohme LLC
$33
Elutia, Inc.
$30
Impulse Dynamics (USA) Inc.
$26
Kowa Pharmaceuticals America, Inc.
$21
Acutus Medical, Inc.
$19
GE HealthCare
$16
ARBOR PHARMACEUTICALS, INC.
$13
MEDICOMP INC
$13
G Medical Diagnostic Services, Inc.
$12
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · ACUITY Steerable · AMPLATZER AMULET · AMVIA EDGE · ANDEXXA · ANGIO-SEAL · Acticor 7 VR-T DX · Agilis NxT EP Introducer · Allure Quadra RF CRT Pacemaker · Arctic Front · Assure WCD · Assurity Pacemaker · AtriCure AtriClip LAA Exclusion System · Azure · BRILINTA · Barostim Neo System · C3 Delivery System · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARTO 3 · CT THROMBECTOMY SYSTEM KIT · Cardiac Monitor · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Confirm Rx · Connectivity and Remote care · Corlanor · CryoFlex · Durata Defibrillation ICD Lead · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · ESOPHAGEAL COOLING DEVICE · Edarbyclor · Edora 8 DR-T · Ellipse ICD · EnSite Precision Cardiac Mapping System · EnSite X · Ensite Cardiac Mapping System · Epi-Sense Guided Coagulation System with VisiTrax · FARXIGA · FLOWTRIEVER CATHETER · Fortify Assura · GENERAL STRUCTURAL HEART · GENERAL THERAPIES · GENERAL - STRUCTURAL HEART · GENERAL - THERAPIES · General - Brady · General - Therapies · JARDIANCE · LEXISCAN · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · Models · MyCareLink · MynxGrip Vascular Closure Device · NA · NEXLETOL · NORTHERA · OCTARAY MAPPING CATHETER · ONPATTRO · OPTIMIZER · PRADAXA · PRALUENT · Pouch · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE EL ICD VR · REVEAL LINQ · Repatha · Resolute · Reveal LINQ · Rhythmia Mapping System · S · TR BAND · TactiCath Quartz CFA Catheter · VERQUVO · VYNDAMAX · VYNDAQEL · VersaCross Access Solution · ViewFlex Xtra ICE Catheter · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch · ZONTIVITY · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $134 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
101
Per 100K population
24.3
County median income
$75,792
Nearest hospital
HCA FLORIDA BLAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Akella is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Akella experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Akella performed 2,048 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akella receive payments from pharmaceutical companies?
Yes. Dr. Akella received a total of $11,697 from 44 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akella's costs compare to other cardiovascular diseases in Bradenton?
Dr. Akella's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akella) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Bradenton
Browse cardiovascular diseases in Bradenton ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology